Intravesical gemcitabine in management of BCG refractory superficial transitional cell carcinoma (TCC) of urinary bladder

被引：0
|
作者：
Mohanty, N. K. [1 ]
Nayak, R. L. [1 ]
Arora, R. P. [1 ]
Saxena, S. [1 ]
机构：
[1] Safdarjang Hosp, VM Med Coll, New Delhi, India
来源：
BJU INTERNATIONAL | 2007年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [41] The use of BCG in superficial carcinoma of the urinary bladder
    Böhle, A
    Durek, C
    [J]. UROLOGE A, 2001, 40 (05): : 403 - 409
  • [42] Cytologic changes associated with intravesical adriamycin therapy for invasive transitional cell carcinoma (TCC) of the bladder
    Callaghan, EJ
    See, WA
    Dreicer, R
    Cohen, MB
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 171 - 171
  • [43] INTRAVESICAL THERAPY IN THE MANAGEMENT OF SUPERFICIAL TRANSITIONAL CELL-CARCINOMA OF THE BLADDER - THE EXPERIENCE OF THE EORTC GU GROUP
    NEWLING, D
    [J]. BRITISH JOURNAL OF CANCER, 1990, 61 (04) : 497 - 499
  • [44] Adjuvant intravesical therapy based on an in vitro cytotoxicity assay in the management of superficial transitional cell cancer of the urinary bladder
    Saxena, Sunita
    Agrawal, Usha
    Agarwal, Abhilasha
    Murthy, Nandagudi Srinivasa
    Mohanty, Nayan Kumar
    [J]. BJU INTERNATIONAL, 2006, 98 (05) : 1012 - 1017
  • [45] IMMUNOTHERAPY OF SUPERFICIAL TRANSITIONAL CELL-CARCINOMA OF THE URINARY-BLADDER WITH BACILLUS-CALMETTE-GUERIN (BCG)
    JAKSE, G
    [J]. AKTUELLE UROLOGIE, 1989, 20 (04) : 192 - 198
  • [46] Phase I trial of intravesical gemcitabine in bacillus Calmette-Guerin-refractory transitional-cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Sheinfeld, J
    Mazumdar, M
    Tong, W
    Rabbani, F
    Donat, MS
    Herr, HW
    Sogani, P
    dePalma, D
    Bojorin, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3193 - 3198
  • [47] A phase 1 dose-escalation trial of intravesical CG0070 for superficial transitional cell carcinoma (TCC) of the bladder after bacillus Calmette-Guerin (BCG) failure
    Lamm, D
    Stephenson, J
    Tsai, H
    Nemunaitis, J
    Goldstein, M
    Arseneau, J
    Neal, K
    Aimi, J
    Yu, D
    Corman, JM
    McKiernan, JM
    Senzer, N
    Burke, JP
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 272 - 272
  • [48] A Phase 1 Dose-Escalation Trial of Intravesical CG0070 for Superficial Transitional Cell Carcinoma (TCC) of the Bladder after Bacillus Calmette-Guerin (BCG) Failure
    Senzer, Neil
    Nemunaitis, John
    Goldstein, Michael
    Arseneau, James
    Lamm, Don
    Stephenson, Joe
    Tsai, Harry
    Neal, Kristina
    Aimi, Junko
    Yu, D. C.
    Maslyar, Daniel
    Corman, John
    Mckiernan, James
    Burke, James
    [J]. MOLECULAR THERAPY, 2006, 13 : S22 - S22
  • [49] Results at 5 years of intra vesical gemcitabine (G) single agent as adjuvant chemotheray in superficial transitional cell carcinoma (TCC) of the bladder
    Smaili, F.
    Bounedjar, A.
    Ferhat, R.
    Bouzid, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder
    Greenberg, RE
    Bahnson, RR
    Wood, D
    Childs, SJ
    Bellingham, C
    Edson, M
    Bamberger, MH
    Steinberg, GD
    Israel, M
    Sweatman, T
    Giantonio, B
    ODwyer, PJ
    [J]. UROLOGY, 1997, 49 (03) : 471 - 475
12345